Vowst (fecal microbiota spores, live-brpk) — United Healthcare
Prevention of recurrence of Clostridioides difficile infection (CDI) following antibacterial treatment for recurrent CDI (rCDI)
Initial criteria
- Diagnosis of recurrent Clostridioides difficile infection (rCDI)
- AND Patient is age ≥ 18 years
- AND Patient has completed antibiotic treatment for rCDI 2 to 4 days prior to initiating Vowst
- AND Vowst is used to prevent the recurrence of CDI
Approval duration
1 month